Gaois

This is a static copy of data that is exported from IATE on an occasional basis. It should not be assumed that information provided about an entry here will always correspond to the current version of the entry in IATE. That current version can be checked by clicking on the link on the upper right hand side of each entry. More information »

1 result

  1. SOCIAL QUESTIONS|health|health policy · SOCIAL QUESTIONS|health|pharmaceutical industry|pharmaceutical product · EUROPEAN UNION|European Union law|EU act

    #689869

    IATE #3645305
    Gníomh um Tháirgí Íocshláinte Criticiúla Reference "Téarmeolaithe COM-GA; arna bhunú ar: Treoirlínte polaitiúla don chéad Choimisiún Eorpach eile 2024-2029, Ursula von der Leyen, Iarrthóir ar Uachtaránacht an Choimisiúin Eorpaigh, an 18 Iúil 2024"
    ga
    Definition gníomh reachtach atá molta arb é is aidhm dó slándáil sholáthar na gcógas san Aontas a neartú Reference "Téarmeolaithe COM-GA; arna bhunú ar: Teachtaireacht ón gCoimisiún: Aghaidh a thabhairt ar ghanntanais cógas leighis san Aontas"
    Rechtsakt zu kritischen Arzneimitteln
    de
    Definition geplanter Vorschlag für einen Rechtsakt, der das Ziel verfolgt, die Versorgungssicherheit der EU bei Medizinprodukten und Arzneimitteln zu verbessern Reference "COM-DE gestützt auf: Politische Leitlinien für die nächste Europäische Kommission 2024 - 2029, Ursula von der Leyen – Kandidatin für das Amt der Präsidentin der Europäischen Kommission, 18.7.2024 (19.7.2024)"
    Critical Medicines Act
    en
    Definition proposed legal act seeking to strengthen the EU’s security of medicines supply Reference "Council PL, based on: Commission Communication: Addressing medicine shortages in the EU"
    Comment A Critical Medicines Act, which should take the form of an EU regulation, would provide an overarching regulatory framework for the following: 1) a legislative framework setting out the process for choosing which APIs are to be reshored in Europe; 2) a financing mechanism to develop industrial infrastructure for producing APIs and finished medicines in Europe (R & D, investment in infrastructure and technology and operating costs during the financing period); 3) relevant EU guidelines on pricing in the European market for finished products, and on reimbursement so that APIs and finished medicines produced in Europe can be competitive.
    acte législatif sur les médicaments critiques | loi sur les médicaments critiques | législation sur les médicaments critiques
    fr
    Definition acte législatif proposé en vue de renforcer les capacités européennes de production de médicaments critiques ainsi que la résilience et l'autonomie stratégique de l'UE dans ce domaine Reference "Conseil-FR, d'après Communication de la Commission - Remédier aux pénuries de médicaments dans l’UE"